Evaluation of a Worksheet for Monitoring Adverse Reactions during Concurrent Chemoradiation

We prepared a work sheet for monitoring adverse reactions in the treatment of advanced cervical cancer with concurrent chemoradiation therapy(CCR)using nedaplatin.We used the worksheet to monitor adverse reactions and their grade.Thirty eight patients(80.4%)out of 46 developed adverse reactions during the CCR,which corresponded with the data on our work sheet.We therefore felt able to use the worksheet in explaining the adverse reactions occurring during CCR to patients.Through its use,the grade and duration of diarrhea occurring as an adverse reaction decreased in most patients.It has enabled us to provide highly useful information on adverse reactions in CCR to physicians and nurses in a timely manner.